title: NIH dengue vaccine leaps into phase 3 studies.
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Perkel
mesh_terms: D001938:Brazil; D003715:Dengue / Q000276:immunology* / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D015195:Drug Design; D006801:Humans; D009316:National Institutes of Health (U.S.); D016896:Treatment Outcome; D014481:United States; D014613:Vaccines, Attenuated / Q000008:administration & dosage* / Q000276:immunology*
chemical_list: D053059:Dengue Vaccines; D014613:Vaccines, Attenuated